| Size | Price | Stock | Qty |
|---|---|---|---|
| 5g |
|
||
| Other Sizes |
| Targets |
Human Endogenous Metabolite
Ac-Ala-OH does not have a well-defined pharmacological target as it is primarily a research tool and metabolite. As an N-acetyl-L-amino acid, it is a substrate for enzymes such as aminoacylase and is involved in amino acid metabolism. It may interact with the enzyme APEH (acylaminoacyl-peptide hydrolase) in inhibition assays. Its "target" in research is the metabolic pathways involving acetylated amino acids. |
|---|---|
| ln Vitro |
In vitro activity of Ac-Ala-OH is evaluated in enzymatic studies, particularly as a substrate or inhibitor for aminoacylases and other amino acid-metabolizing enzymes. It is also used as a reference standard in LC-MS/MS metabolomics workflows for chromatographic peak annotation. Its "activity" is reflected in its role as a stable, N-terminally protected amino acid building block.
|
| ln Vivo |
In vivo, Ac-Ala-OH is an endogenous metabolite involved in amino acid metabolism. As an N-acetylated amino acid, it is formed by the acetylation of alanine and can be deacetylated by aminoacylases. Its levels in biological fluids reflect amino acid metabolism and may be altered in metabolic disorders. It is not a therapeutic agent.
|
| Enzyme Assay |
In vitro enzyme assays with Ac-Ala-OH typically involve studying aminoacylases or other enzymes that recognize N-acetylated amino acids. The compound is used as a substrate to measure enzyme activity or as an inhibitor in screening assays. Standard assays involve incubating the compound with enzyme preparations and monitoring the release of alanine or the consumption of the substrate by spectrophotometric or chromatographic methods.
|
| Cell Assay |
Ac-Ala-OH is not typically used as a bioactive compound in cell culture experiments. However, it may be employed in studies investigating amino acid metabolism or as a supplement in defined media. Cells could be treated with the compound to study its effects on cellular metabolism, but its primary use is as a chemical building block and analytical standard.
|
| Animal Protocol |
In vivo animal experiments with Ac-Ala-OH are not commonly performed as the compound is a metabolite rather than a therapeutic agent. If used, it would be to study amino acid metabolism or to validate analytical methods for measuring N-acetylated amino acids in biological samples. Its primary significance is in research as a reference standard and building block.
|
| ADME/Pharmacokinetics |
The pharmacokinetic (PK) properties of Ac-Ala-OH are consistent with those of N-acetylated amino acids. As a small, polar molecule, it is readily absorbed and distributed throughout the body. It is likely metabolized by aminoacylases to release alanine and acetate. Specific PK data are not available as the compound is a metabolite rather than a drug.
|
| Toxicity/Toxicokinetics |
Ac-Ala-OH has a low toxicity profile as it is a naturally occurring metabolite. It is not considered a hazardous substance. For research use, standard laboratory safety practices are sufficient. It has a melting point of 122-128°C and an optical rotation of approximately -64°. Comprehensive toxicology studies have not been published.
|
| Additional Infomation |
N-acetyl-L-alanine is an N-acetyl-L-amino acid formed by replacing a hydrogen atom on the nitrogen atom of L-alanine with an acetyl group. It is a metabolite found in both humans and Saccharomyces cerevisiae. It is a derivative of L-alanine and also an N-acetyl-L-amino acid. It is the conjugate acid of N-acetyl-L-alanine. N-acetyl-L-alanine is a metabolite found or produced in Escherichia coli (strains K12 and MG1655). It has also been reported to exist in Drosophila melanogaster, Candida tropicalis, and other organisms with relevant data. N-acetyl-L-alanine is a metabolite found or produced in Saccharomyces cerevisiae.
Ac-Ala-OH (N-Acetyl-L-alanine) is an N-terminally protected L-alanine derivative used as a building block for peptide synthesis and as an endogenous metabolite in metabolomics research. It is a stable, chiral compound with a permanent, non-cleavable N-acetyl cap. It is not a drug and has no therapeutic indications. It is available for laboratory research use only. |
| Molecular Formula |
C5H9NO3
|
|---|---|
| Molecular Weight |
131.13
|
| Exact Mass |
131.058
|
| CAS # |
97-69-8
|
| Related CAS # |
Ac-Ala-OH-d3;1485548-36-4;Ac-Ala-OH-d4;2230887-18-8
|
| PubChem CID |
88064
|
| Appearance |
White to off-white solid powder
|
| Density |
1.2±0.1 g/cm3
|
| Boiling Point |
369.7±25.0 °C at 760 mmHg
|
| Melting Point |
125-126°C
|
| Flash Point |
177.4±23.2 °C
|
| Vapour Pressure |
0.0±1.8 mmHg at 25°C
|
| Index of Refraction |
1.455
|
| LogP |
-1.07
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
9
|
| Complexity |
132
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
C[C@@H](C(=O)O)NC(=O)C
|
| InChi Key |
KTHDTJVBEPMMGL-VKHMYHEASA-N
|
| InChi Code |
InChI=1S/C5H9NO3/c1-3(5(8)9)6-4(2)7/h3H,1-2H3,(H,6,7)(H,8,9)/t3-/m0/s1
|
| Chemical Name |
(2S)-2-acetamidopropanoic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 100 mg/mL (762.60 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (19.07 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (19.07 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (19.07 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.6260 mL | 38.1301 mL | 76.2602 mL | |
| 5 mM | 1.5252 mL | 7.6260 mL | 15.2520 mL | |
| 10 mM | 0.7626 mL | 3.8130 mL | 7.6260 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.